When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MLNT - Melinta Therapeutics' Latest News Has Been Wildly Misunderstood
Melinta Therapeutics Inc - Ordinary Shares
Melinta Therapeutics (MLNT) is a pharmaceutical company specialising in the development of treatments for bacterial infections. On Wednesday, June 19, we saw a huge spike in the stock price from $2 to over $6 at one point on news that the FDA had accepted a supplemental New Drug Application ((SNDA)) for priority review for MLNT's BAXDELA (delafloxacin) drug to include patients with community-acquired bacterial pneumonia ((CABP)). Rather than being anything ground-breaking, however, it is my view that this news was to be expected, and the obscene market reaction to it is largely due to misunderstanding